EICHORCondition: Hemophilia A With Inhibitor · Hemophilia B With Inhibitor · Sponsor: Catalyst Biosciences
The purpose of the trial is to evaluate the safety and efficacy of MarzAA for on-demand treatment and control of bleeding episodes in hemophilia A or B patients with inhibitors compared with their standard of care (SOC).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Diagnosis of congenital hemophilia A or B with inhibitors * Male or Female, age 12 or older * History of frequent bleeding episodes * Affirmation of informed consent with signature confirmation and assent for children between ages 12 to 17 before any study related activities Exclusion Criteria: * Previous participation in a clinical trial evaluating a modified rFVIIa agent * Received an investigational drug within 30 days or 5 half-lives or absence of clinical effect * Known hypersensitivity to trial or related product * Known positive antibody to FVII or FVIIa detected by central lab at screening * Have a coagulation disorder other than hemophilia A or B * Be immunosuppressed * Significant contraindication to participate
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | — |
| Lombardi Comprehensive Cancer Center | Washington D.C., District of Columbia, United States | — |
| Hematology Center after Prof. R. Yeolyan | Yerevan, Armenia | — |
| JSC "K.Eristavi National Center of Experimental and Clinical Surgery" | Tbilisi, Georgia | — |
| Magyar Honvédség Egészségügyi Központ, Országos Haemophilia Központ | Budapest, Hungary | — |
| Nirmal Hospital | Gujrāt, India | — |
| K.L.E.S Dr. Prabhakar Kore Hospital and Medical Research Centre | Kārnād, India | — |
| Sanjay Gandhi Postgraduate Institute of Medical Sciences | Lucknow, India | — |
| K.J Somaiya Hospital and Research Centre | Mumbai, India | — |
| MCGM - Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & BMT Centre | Mumbai, India | — |
| Sahyadri Specialty Hospital | Mumbai, India | — |
| Grant Medical Foundation, Ruby Hall Clinic | Pune, India | — |
+ 31 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04489537